Hold JPM at $356: franchise quality too strong to abandon but entry at 52-week highs justifies benchmark weight with light UW tilt preference
The franchise quality (17.79% ROE, $102B annualized NII, $8.79B/quarter buyback floor, $52B annualized capital returns, 9.3% share count reduction since FY22) is too powerful to abandon, but the entry point at 52-week highs and 90th+ percentile of JPM's 10-year forward P/E range offers asymmetric downside into clustered Q3 catalysts. The aggressive analyst correctly identifies the NII tailwind and buyback floor but conflates franchise quality with entry timing; the conservative analyst correctly identifies the failed breakouts and leverage expansion but overreaches with the credit-cycle analogy. The binding 8/21 lesson rules out Underweight until confirmed 50 SMA break with volume expansion; the binding 8/25 lesson rules out Overweight when four-plus technicals flash caution simultaneously. Q2's $7.70 EPS (~23% above the ~$6.25/quarter forward consensus) confirms Q2 as cyclical peak rather than new baseline. The cleanest reassessment setup awaits Q3 2026 earnings to resolve Q2 comp-distortion, NII trajectory under 86% no-cut pricing, Fed formula ruling, and card credit quality.
| Position | Action |
|---|---|
| Each add tranche | Sized at half original position size |
JPM is in a structural earnings acceleration phase with NII tailwinds from higher-for-longer rates, a 9.3% annual share-count reduction compounding EPS, and widening competitive moats in fee-rich businesses.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 356.32 | neutral |
| 50 SMA | 346.88 | bullish |
| 200 SMA | 315.01 | bullish |
| MACD Line | 2.43 | neutral |
| MACD Histogram | -1.48 | bearish |
| RSI | 53.40 | neutral |
| Bollinger Upper Band | 365.96 | bearish |
| Bollinger Middle Band | 358.03 | neutral |
| Bollinger Lower Band | 350.10 | bullish |
| ATR | 5.74 | neutral |
Support: 350.1 · 346.88 | Resistance: 358.03 · 365.96
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: $367.62+ on breakout confirmation
Then: Add half original position size
EV: +6.3% (from $356 to $366 retest) then +6.7% to $380+ · concedes: Short-term MACD bearish crossover noted; RSI at 53 (neutral/dead-center); 1.6% pullback from August peak acknowledged; Stock +158.6% over three years and +20.6% in three months — premium valuation acknowledged; PEG ratio of 1.73 described as elevated
JPMorgan is a high-quality franchise priced for its best-case scenario — Q2 2026's record $7.70 EPS is a cyclical high-water mark, not a new baseline, and credit/regulatory/macro risks converging under a hawkish Warsh Fed are fundamentally underpriced at $356.
· concedes: Q2's $7.70 EPS is 'roughly 10-15 percentage points' bought growth — the remaining ~32-37 percentage points is genuine organic EPS growth; NII growth from $66.71B to $95.44B is real; JPM is a high-quality franchise with genuine competitive strengths; The Fishman hire and lending rule relaxation represent real strategic moves, even if the bear disputes their durability as moats
→ vs conservative: The conservative analyst wants to wait for $340-348 entry, but that only provides ~4.3% better entry versus missing ongoing buyback compounding, NII prints, and Fishman-led tech M&A fees. The analyst is anchored to technicals that assume mean reversion in a name whose entire investment thesis is structural outperformance.
→ vs conservative: Conservative P/E premium argument is a category error — JPM should not be valued like a C or regional bank given its 17.79% ROE versus 10-12% peer median.
→ vs conservative: The macro setup is structurally bullish for JPM (89% odds of zero Fed cuts in 2026) and represents a structural NII tailwind extending through year-end and into 2027, not a headwind.
→ vs neutral: The MACD crossover and two failed breakouts at $366.50 is not a distribution top — price is compressing in a Bollinger squeeze with ATR at 5.74, which in a confirmed long-term uptrend resolves higher with materially higher probability than lower.
→ vs neutral: Operating cash flow concern of negative $190 billion over two years is meaningless for a bank — it's a GAAP accounting artifact of loan originations versus wholesale funding flows, not actual capital generation weakness.
→ vs neutral: Being at benchmark weight while the buyback yields 5% and the volatility squeeze is about to resolve higher means underperforming when confirmation arrives after the move is over in a momentum regime.
→ vs neutral: The 'hold with preferred add zone at $340-348' is too cute — technical support at $346.88 (50 SMA) and $350.10 (Bollinger lower) may not get retested cleanly, and if they are, they likely get bought aggressively.
JPM is in a long-term uptrend (price +13% above 200 SMA) but has stalled in the near term following a powerful rally from early June ($300) to mid-August peak ($366). MACD bearish crossover and negative histogram indicate weakening momentum, while RSI at 53.40 shows equilibrium. Bollinger Band width compression signals a potential volatility squeeze. Key support sits at $350.10 (lower band) and $346.88 (50 SMA), with resistance at $358.03 (midline) and $365.96 (upper band). The current recommendation is HOLD for existing positions while awaiting confirmation of either trend resumption above $358 or deeper correction below $346.88.
Market Cap
$946.37 billion
P/E Ratio (TTM)
15.25x
Forward P/E
14.24x
PEG Ratio
1.73
Price to Book
2.68x
EPS (TTM)
$23.35
Forward EPS
$25.01
Dividend Yield
1.68%
Beta
0.98
52-Week High
$366.50
52-Week Low
$279.10
Book Value per Share
$133.01
TTM Revenue
$186.33 billion
Profit Margin (TTM)
34.92%
Operating Margin
50.39%
Return on Equity (ROE)
17.79%
Return on Assets (ROA)
1.36%
Total Assets
$5.02 trillion
Net Loans
$1.52 trillion
Stockholders' Equity
$374.6 billion
Tangible Book Value
$289.25 billion
Net Interest Income (FY2025)
$95.44 billion
Net Interest Income (Q2 2026)
$25.51 billion
FY2025 Buybacks
$31.59 billion
FY2025 Dividends
$16.63 billion
Share Count Reduction
-9.3%
Net Loans / Assets
30.2%
Trading Securities
$794 billion
Effective Tax Rate (FY2025)
21.4%
Revenue 2022
$127.73 billion
Revenue 2025
$181.85 billion
Net Income 2022
$37.68 billion
Net Income 2025
$57.05 billion
Diluted EPS FY2025
$20.02
Q2 2026 Diluted EPS
$7.70
Total Debt
$532.95 billion
Common Stock Equity
$353.56 billion
Preferred Stock
$21.04 billion
Retained Earnings
$445.02 billion
50-Day Moving Average
$347.21
200-Day Moving Average
$317.15
Strengths
Concerns
JPMorgan Chase & Co. (NYSE: JPM) is the largest U.S. bank holding company by assets ($5.02T as of Q2 2026), operating four segments: Consumer & Community Banking, Corporate & Investment Banking, Commercial Banking, and Asset & Wealth Management. The bank has demonstrated exceptional fundamental strength with revenue growing 42.4% from 2022 to 2025 ($127.73B to $181.85B), net income expanding 51.4% over the same period, and Q2 2026 delivering record quarterly EPS of $7.70 (+47% YoY). Key competitive advantages include a 17.79% ROE and 1.36% ROA (well above large-cap bank peers), consistent Net Interest Income expansion in a higher-rate environment ($66.71B to $95.44B), and an accelerating capital return program with buybacks tripling from $10.60B to $31.59B over four years. The stock trades at 15.25x trailing P/E and 2.68x P/B—premium valuations reflecting JPM's franchise quality and earnings consistency—with the stock near its 52-week high of $366.50 and above both its 50-day and 200-day moving averages. Primary risks include $1.52T in net loans (credit-cycle sensitivity), $794B in trading securities (mark-to-market volatility), and the bank's systemic importance引来 global regulatory scrutiny.
Macro: Fed Chair Kevin Warsh rejected the wage-push inflation framework at Jackson Hole, catalyzing a regime repricing with 89% odds of zero Fed rate cuts in 2026 (up +2.2pp week-over-week); Polymarket shows ~$7.7M traded with all '6+ cuts' scenarios at 0%. Recession odds remain low at 8%. Higher-for-longer rates are structurally supportive for bank NII but elevate card/consumer credit risk and pressure equity-market-linked revenues. Middle East military strikes renewed, weighing on gold and rate-sensitive commodities.